NYSE:ALB - Albemarle Stock Price, Forecast & News

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle announced a quarterly dividend on Tuesday, October 29th. Stockholders of record on Friday, December 13th will be paid a dividend of $0.368 per share on Thursday, January 2nd. This represents a $1.47 annualized dividend and a dividend yield of 1.81%. The ex-dividend date of this dividend is Thursday, December 12th. This is a positive change from Albemarle's previous quarterly dividend of $0.37. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) announced its quarterly earnings data on Wednesday, November, 6th. The specialty chemicals company reported $1.53 EPS for the quarter, beating analysts' consensus estimates of $1.49 by $0.04. The specialty chemicals company had revenue of $879.70 million for the quarter, compared to analyst estimates of $883.67 million. Albemarle had a net margin of 16.27% and a return on equity of 15.94%. The firm's revenue for the quarter was up 13.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.31 earnings per share. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Albemarle.

Albemarle issued an update on its FY 2024 Pre-Market earnings guidance on Thursday, December, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $4.4-5 billion.

23 Wall Street analysts have issued twelve-month target prices for Albemarle's shares. Their forecasts range from $39.50 to $128.00. On average, they expect Albemarle's stock price to reach $79.84 in the next year. This suggests that the stock has a possible downside of 1.9%. View Analyst Price Targets for Albemarle.

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 4 sell ratings, 9 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Albemarle.

Media coverage about ALB stock has trended somewhat positive recently, according to InfoTrie. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Albemarle earned a news sentiment score of 1.6 on InfoTrie's scale. They also gave media coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Albemarle.

Some companies that are related to Albemarle include Ecolab (ECL), Sherwin-Williams (SHW), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), NewMarket (NEU), W. R. Grace & Co (GRA), Ashland Global (ASH), Balchem (BCPC), Quaker Chemical (KWR), PolyOne (POL), Sensient Technologies (SXT), Innospec (IOSP), HB Fuller (FUL) and Stepan (SCL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Rogers Communications (RCI), Open Text (OTEX) and Valeant Pharmaceuticals Intl (VRX).

Albemarle's stock is owned by a variety of of retail and institutional investors. Top institutional investors include SPF Beheer BV (1.05%), KAMES CAPITAL plc (0.69%), Commerzbank Aktiengesellschaft FI (0.34%), Hahn Capital Management LLC (0.18%), Zurcher Kantonalbank Zurich Cantonalbank (0.18%) and OLD National Bancorp IN (0.08%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Janney Capital Management LLC, Leavell Investment Management Inc., IFP Advisors Inc, Zurcher Kantonalbank Zurich Cantonalbank, Hahn Capital Management LLC, SFE Investment Counsel, AE Wealth Management LLC and State of Alaska Department of Revenue. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam and Scott Tozier. View Insider Buying and Selling for Albemarle.

ALB stock was purchased by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, SPF Beheer BV, Deane Retirement Strategies Inc., Tocqueville Asset Management L.P., OLD Second National Bank of Aurora, Mission Wealth Management LP, Kempner Capital Management Inc. and Red Spruce Capital LLC. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow and Eric Norris. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $81.38.

Albemarle has a market capitalization of $8.63 billion and generates $3.37 billion in revenue each year. The specialty chemicals company earns $693.56 million in net income (profit) each year or $5.48 on an earnings per share basis. Albemarle employs 5,900 workers across the globe.View Additional Information About Albemarle.

The official website for Albemarle is http://www.albemarle.com/.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]